Journal of Pharmaceutical Policy and Practice
Volume 17, 2024 - Issue 1
Brief Report
Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016–2019 data
Omar Qureshia Yale School of Medicine, New Haven, CT, USA
https://orcid.org/0000-0002-2268-4648View further author information
https://orcid.org/0000-0002-2268-4648View further author information, Reshma Ramachandranb Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA;c Yale Collaboration for Regulatory Rigor, Integrity and Transparency (CRRIT), Yale School of Medicine, New Haven, CT, USAhttps://orcid.org/0000-0003-3845-3606View further author information
https://orcid.org/0000-0003-3845-3606View further author information & Joseph S. Rossb Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA;c Yale Collaboration for Regulatory Rigor, Integrity and Transparency (CRRIT), Yale School of Medicine, New Haven, CT, USA;d Department of Health Policy and Management, Yale School of Public Health; and Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT, USACorrespondence[email protected]
https://orcid.org/0000-0002-9218-3320View further author information
https://orcid.org/0000-0002-9218-3320View further author information